Nick Dempsey
Thanks. Can I just tack on a quick follow-up. Would you ever think of doing this with your journal content? Or is that more complicated by the monetization model for journals, relationship with authors, et cetera?
Jay Flynn
So, let me
stress that these
deals -- none of these
deals are what I would
characterize as simple,
right? In the book
world and the
journal world
and the database
world, we were
very clear that we
have to exercise
diligence and we
have to be very clear
on rights and things
like that. What I will
say is that there will
be opportunities
for us to explore
licensing both journal
and book content.
journal content is
increasingly relevant
in the AI context
for the markets
that Matt just
mentioned.
And in the context
of large corporate
R&D, in the context
of engineering
and physics
and medicine.
And so, when
those opportunities
present themselves,
we'll explore.
A lot of these companies
buy our content
already.
And so,
one of the things
they're certainly interested in
and we're certainly interested in
is talking to them about acquiring
rights to use that content in ways
that are integrated into
their own AI programs.
And of course,
as I said before,
we have opportunities
to use AI
to develop our own products
and services
there, too.
https://seekingalpha.com/article/4699135-john-wiley-and-sons-inc-wly-q4-2024-earnings-call-transcript
Roman Ryan 